View drug registration information details.
| Items | Registration information |
|---|
| ID | 2218 |
|---|
| No | 2218 |
|---|
| Brand Name | SEA-MOX TABLETS 400 MG |
|---|
| Ingredients | MOXIFLOXACIN (AS HYDROCHLORIDE) 400 MG |
|---|
| Dosage Form | TABLETS
|
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 5'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | INDICATED FOR TREATMENT OFTHE FOLLOWING BACTERIAL INFECTIONS IN PATIENTS OF 18 YEARS OF AGE AND OLDER CAUSED BY BACTERIA SUCEPTIBLE TO MOXIFLOXACIN: ACUTE BACTERIA SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, EXCEPT SEVERE CASES, MILD TO MODERATE PELVIC INFLAMMATORY DISEASE, COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SKIN STRUCTURE INFECTION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | ORANGE COLOR, OVAL SHAPED, FILM COATED TABLET ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | POUNSAB PHARMA CO.,LTD |
|---|
| Manufacturer | THE SEARLE COMPANY LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 05 I 5534/23 |
|---|
| FDD Registration Date | 15-MAY-2023 |
|---|
| Expiry Date | 14-MAY-2026 |
|---|
Back to drug list
|
